Multiple sclerosis: open trials in Czechia

20 open trials have a site in Czechia. Registry data; only the trial team decides who can take part.

NCT07067463
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC
Fakultni nemocnice Brno, Brno · Fakultni Nemocnice U Sv Anny V Brne, Brno-Stred · NEUROHK s r o, Choceň · Fakultni nemocnice Hradec Kralove, Hradec Králové · University Hospital Olomouc, Olomouc · Krajska zdravotni a.s., Teplice
Registry updated 2026-11-03
2024-517745-14-00
Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368, a FAAH/MAGL Inhibitor, in Participants with Multiple Sclerosis Spasticity
Trial Treatment · Phase 2 · Celgene Corp.
Fakultni Nemocnice U Sv Anny V Brne, Brno-Stred · Fakultni nemocnice Hradec Kralove, Hradec Králové · Nemocnice Pardubickeho kraje a.s., Pardubice · Vseobecna Fakultni Nemocnice V Praze, Prague 2 · Fakultni Thomayerova nemocnice, Prague 4 · Krajska zdravotni a.s., Teplice · Krajska Nemocnice T Bati a.s., Zlin
Registry updated 2026-10-30
NCT07827586
Non-interventional Study of Subcutaneous Ocrelizumab in Persons With Relapsing-Remitting Multiple Sclerosis
Research · Hoffmann-La Roche
Nemocnice Pardubickeho kraje, a.s., Pardubicka nemocnice, Pardubice
Registry updated 2026-10-30
2023-504358-36-00
Efficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis
Trial Treatment · Phase 3 · Sanofi-Aventis Recherche & Developpement
Fakultni Nemocnice U Sv Anny V Brne, Brno-Stred · Nemocnice Jihlava prispevkova organizace, Jihlava 1 · Fakultni Nemocnice Hradec Kralove, Novy Hradec Kralove · Nemocnice Pardubickeho kraje a.s., Pardubice · Krajska Nemocnice T Bati a.s., Zlin
Registry updated 2026-10-28
NCT06782490
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
Trial Treatment · Phase 2 · Celgene
Fakultni nemocnice u sv. Anny v Brne, Brno · Fakultni nemocnice Hradec Kralove, Hradec Králové · Nemocnice Pardubickeho kraje, Pardubice · Fakultni Thomayerova nemocnice, Prague · Vseobecna fakultni nemocnice v Praze, Prague · Local Institution - 0011, Prague · Nemocnice Teplice, Teplice · Local Institution - 0077, Zlín
Registry updated 2026-10-27
NCT07299019
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Zenas BioPharma (USA), LLC
Fakultni nemocnice Brno, Brno · NEUROHK s r o, Choceň · Fakultni nemocnice Hradec Kralove, Hradec Králové · Nemocnice Jihlava prispevkova organizace, Jihlava 1 · University Hospital Olomouc, Olomouc · Fakultni nemocnice Ostrava, Ostrava · Fakultni nemocnice Kralovske Vinohrady, Prague · Krajska Nemocnice T Bati a.s., Zlin
Registry updated 2026-10-27
NCT06846281
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Fakultni nemocnice Brno, Brno · Fakultni Nemocnice U Sv Anny V Brne, Brno-Stred · Fakultni nemocnice Hradec Kralove, Hradec Králové · Nemocnice Jihlava prispevkova organizace, Jihlava 1 · Nemocnice Pardubickeho kraje a.s., Pardubice · Fakultni Nemocnice Motol a Homolka, Prague
Registry updated 2026-10-26
NCT05054140
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients with Progressive Multiple Sclerosis
Trial Treatment · Phase 2 · Immunic AG
Fakultni Nemocnice Hradec Kralove, Novy Hradec Kralove · Krajska zdravotni a.s., Teplice
Registry updated 2026-10-23
2024-512914-16-00
A Randomized, Double-blind, Study to Demonstrate Pharmacokinetic Similarity, and Evaluate Safety, Immunogenicity, Pharmacodynamics and Clinical Effects between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects with Relapsing-remitting Multiple Sclerosis
Trial Treatment · Phase 3 · Amgen Inc.
Fakultni Nemocnice U Sv Anny V Brne, Brno-Stred · Neurologie Rs Centrum s.r.o., Hradec Kralove · Nemocnice Jihlava prispevkova organizace, Jihlava 1 · Fakultni Nemocnice Hradec Kralove, Novy Hradec Kralove · Krajska zdravotni a.s., Teplice
Registry updated 2026-10-20
NCT07225504
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Novartis Investigative Site, Brno · Novartis Investigative Site, Hradec Králové · Novartis Investigative Site, Jihlava · Novartis Investigative Site, Prague · Novartis Investigative Site, Teplice
Registry updated 2026-10-13
NCT07360886
Early Detection of Selected Neuropathologies in Motor Vehicle Drivers
Research · University Hospital Olomouc
University Hospital Olomouc, Olomouc
Registry updated 2026-09-08
2024-512707-40-00
A Phase 2 Study of Obexelimab in Patients with Relapsing Multiple Sclerosis
Trial Treatment · Phase 2 · Zenas Biopharma (USA) LLC
Fakultni Nemocnice U Sv Anny V Brne, Brno-Stred · Nemocnice Jihlava prispevkova organizace, Jihlava 1 · Vseobecna Fakultni Nemocnice V Praze, Prague 2
Registry updated 2026-08-27
2025-521546-23-00
A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
Trial Treatment · Phase 3 · Novartis Pharma AG
Fakultni Nemocnice U Sv Anny V Brne, Brno-Stred · Fakultni nemocnice Hradec Kralove, Hradec Králové · Nemocnice Jihlava prispevkova organizace, Jihlava 1 · Fakultni Thomayerova nemocnice, Prague · Fakultni nemocnice v Motole, Prague · Krajska zdravotni a.s., Teplice
Registry updated 2026-07-30
NCT07666958
Comprehensive Rehabilitation Programme in People With Multiple Sclerosis: The RECONNECT-MS Study
Trial Treatment · Charles University, Czech Republic
University Hospital Kralovske Vinohrady, Department od Rehabilitation Medicine, Prague
Registry updated 2026-06-24
NCT06782724
Psilocybin Therapy for Psychological Distress in Palliative Patients
Trial Treatment · Phase 2 · University Medical Center Groningen
Narodni Ustav Dusevniho Zdravi, Klecany
Registry updated 2026-05-08
NCT06280755
Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
Research · icometrix
General University Hospital Prague, Prague
Registry updated 2025-12-12
NCT07032246
Clinical Impact Through AI-assisted MS Care - A Prospective Multi-center Study
Trial Treatment · icometrix
General University Hospital Prague, Prague
Registry updated 2025-12-09
NCT07248657
Comprehensive Therapeutic Program For People With Multiple Sclerosis
Trial Treatment · Charles University, Czech Republic
Assossiation for Body in Balance, Prague
Registry updated 2025-12-01
2024-514549-12-00
The use of therapeutic monitoring of ocrelizumab serum concentrations for personalized pharmacotherapy of relapsing-remitting and primary progressive multiple sclerosis
Trial Treatment · Phase 4 · Fakultni Nemocnice Ostrava
Fakultni nemocnice Ostrava, Ostrava
Registry updated 2025-09-05
NCT06218927
The Effect of Autologous Hematopoietic Stem Cell Transplantation on the Lower Urinary Tract Function Related to QoL in MS Patients
Research · University Hospital Ostrava
University Hospital Ostrava, Ostrava
Registry updated 2024-01-23

All Multiple sclerosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error